Spineway Reports Positive Third Quarter Revenue Growth

The Spineway Group, known for its innovative spine disorder implants, recorded a revenue increase in the third quarter of 2025. The company reported €3.0 million in revenue, up from €2.6 million during the same period in 2024, marking an 18% rise. This increase was primarily driven by deferred orders from major clients.

Spineway's Premium ranges contributed significantly to the sales boost, bringing the nine-month revenue to €8.6 million, a 5% decrease compared to the previous year. Despite supply chain issues, these sales almost closed the gap observed earlier in the year.

Notably, Latin America and Asia showed impressive growth with sales surges of 55% and 23%, respectively. Export sales, accounting for 80% of the consolidated revenue, benefited from a restructured distributor network favoring the Premium ranges.